Updated guidelines for the management of Parkinson's disease.
New data on diagnosis, drug therapy, surgery and psychosocial concerns have emerged since the publication of the 1998 Guidelines for the Management of Parkinson's Disease. This article reviews new data and addresses issues left unanswered in the previous guidelines.
Bhatia
K
K
University Department of Clinical Neurology, Institute of Neurology, London.
Brooks
D J
DJ
Burn
D J
DJ
Clarke
C E
CE
Grosset
D G
DG
MacMahon
D G
DG
Playfer
J
J
Schapira
A H
AH
Stewart
D
D
Williams
A C
AC
D000368:Aged; D001334:Automobile Driving / Q000331:legislation & jurisprudence; D065098:Catechol O-Methyltransferase Inhibitors; D003704:Dementia / Q000209:etiology / Q000628:therapy; D003863:Depression / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D018491:Dopamine Agonists / Q000627:therapeutic use; D004599:Electric Stimulation Therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005917:Globus Pallidus / Q000601:surgery; D006801:Humans; D008875:Middle Aged; D010300:Parkinson Disease / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D013788:Thalamus / Q000601:surgery; D015899:Tomography, Emission-Computed, Single-Photon; D016896:Treatment Outcome
D065098:Catechol O-Methyltransferase Inhibitors; D018491:Dopamine Agonists; D004791:Enzyme Inhibitors